Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4+ T Cells

Biomacromolecules

Volumn 16, Issue 11, 2015, Pages 3425-3433

  Hayder, Myriam ^a,b   Varilh, Marjorie ^a,b   Turrin, Cédric Olivier ^b,c   Saoudi, Abdelhadi ^a,b   Caminade, Anne Marie ^b,c   Poupot, Rémy ^a,b   Liblau, Roland S ^a,b  

^a CHU PURPAN   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMERS; DISEASES; FUNCTIONAL POLYMERS;

CHRONIC INFLAMMATORY DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE SCLEROSIS; NEUROINFLAMMATION; POLYFUNCTIONAL; POTENTIAL DRUG; T-CELL RESPONSE; THERAPEUTIC BENEFITS;

T-CELLS;

AMINO BIS(METHYLENE PHOSPHONATE) DENDRIMER; ANTIINFLAMMATORY AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DENDRIMER; FINGOLIMOD; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; PHOSPHORUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CEREBELLUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFICACY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TREATMENT RESPONSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRIMERS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PHOSPHORUS;

EID: 84946576222     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/acs.biomac.5b00643     Document Type: Article

References (54)

1. Noseworthy, J. H.; Lucchinetti, C.; Rodriguez, M.; Weinshenker, B. G. Multiple sclerosis N. Engl. J. Med. 2000, 343 (13) 938-52 10.1056/NEJM200009283431307
2. Compston, A.; Coles, A. Multiple sclerosis Lancet 2002, 359 (9313) 1221-31 10.1016/S0140-6736(02)08220-X
3. Steinman, L. Immunology of relapse and remission in multiple sclerosis Annu. Rev. Immunol. 2014, 32, 257-81 10.1146/annurev-immunol-032713-120227
4. Giovannoni, G.; Southam, E.; Waubant, E. Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence Mult Scler 2012, 18 (7) 932-46 10.1177/1352458511433302
5. Bloomgren, G.; Richman, S.; Hotermans, C.; Subramanyam, M.; Goelz, S.; Natarajan, A.; Lee, S.; Plavina, T.; Scanlon, J. V.; Sandrock, A.; Bozic, C. Risk of natalizumab-associated progressive multifocal leukoencephalopathy N. Engl. J. Med. 2012, 366 (20) 1870-80 10.1056/NEJMoa1107829
6. Hunter, Z.; McCarthy, D. P.; Yap, W. T.; Harp, C. T.; Getts, D. R.; Shea, L. D.; Miller, S. D. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease ACS Nano 2014, 8 (3) 2148-60 10.1021/nn405033r
7. Hayder, M.; Fruchon, S.; Fournie, J. J.; Poupot, M.; Poupot, R. Anti-inflammatory properties of dendrimers per se Sci. World J. 2011, 11, 1367-82 10.1100/tsw.2011.129
8. Caminade, A. M.; Laurent, R.; Majoral, J. P. Characterization of dendrimers Adv. Drug Delivery Rev. 2005, 57 (15) 2130-46 10.1016/j.addr.2005.09.011
9. Blattes, E.; Vercellone, A.; Eutamene, H.; Turrin, C. O.; Theodorou, V.; Majoral, J. P.; Caminade, A. M.; Prandi, J.; Nigou, J.; Puzo, G. Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (22) 8795-800 10.1073/pnas.1221708110
10. Dernedde, J.; Rausch, A.; Weinhart, M.; Enders, S.; Tauber, R.; Licha, K.; Schirner, M.; Zugel, U.; von Bonin, A.; Haag, R. Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (46) 19679-84 10.1073/pnas.1003103107
11. Tang, Y.; Han, Y.; Liu, L.; Shen, W.; Zhang, H.; Wang, Y.; Cui, X.; Wang, Y.; Liu, G.; Qi, R. Protective Effects and Mechanisms of G5 PAMAM Dendrimers against Acute Pancreatitis Induced by Caerulein in Mice Biomacromolecules 2015, 16 (1) 174-82 10.1021/bm501390d
12. Teo, I.; Toms, S. M.; Marteyn, B.; Barata, T. S.; Simpson, P.; Johnston, K. A.; Schnupf, P.; Puhar, A.; Bell, T.; Tang, C.; Zloh, M.; Matthews, S.; Rendle, P. M.; Sansonetti, P. J.; Shaunak, S. Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers EMBO Mol. Med. 2012, 4 (9) 866-81 10.1002/emmm.201201290
13. Chauhan, A. S.; Diwan, P. V.; Jain, N. K.; Tomalia, D. A. Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers Biomacromolecules 2009, 10 (5) 1195-202 10.1021/bm9000298
14. Klementieva, O.; Aso, E.; Filippini, D.; Benseny-Cases, N.; Carmona, M.; Juves, S.; Appelhans, D.; Cladera, J.; Ferrer, I. Effect of poly(propylene imine) glycodendrimers on beta-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease Biomacromolecules 2013, 14 (10) 3570-80 10.1021/bm400948z
15. Klajnert, B.; Wasiak, T.; Ionov, M.; Fernandez-Villamarin, M.; Sousa-Herves, A.; Correa, J.; Riguera, R.; Fernandez-Megia, E. Dendrimers reduce toxicity of Abeta 1-28 peptide during aggregation and accelerate fibril formation Nanomedicine 2012, 8 (8) 1372-8 10.1016/j.nano.2012.03.005
16. Wasiak, T.; Ionov, M.; Nieznanski, K.; Nieznanska, H.; Klementieva, O.; Granell, M.; Cladera, J.; Majoral, J. P.; Caminade, A. M.; Klajnert, B. Phosphorus dendrimers affect Alzheimer's (Abeta1-28) peptide and MAP-Tau protein aggregation Mol. Pharmaceutics 2012, 9 (3) 458-69 10.1021/mp2005627
17. Marchand, P.; Griffe, L.; Poupot, M.; Turrin, C. O.; Bacquet, G.; Fournie, J. J.; Majoral, J. P.; Poupot, R.; Caminade, A. M. Dendrimers ended by non-symmetrical azadiphosphonate groups: synthesis and immunological properties Bioorg. Med. Chem. Lett. 2009, 19 (14) 3963-6 10.1016/j.bmcl.2009.03.003
18. Rolland, O.; Turrin, C. O.; Bacquet, G.; Poupot, R.; Poupot, M.; Caminade, A. M.; Majoral, J. P. Efficient synthesis of phosphorus-containing dendrimers capped with isosteric functions of amino-bismethylene phosphonic acids Tetrahedron Lett. 2009, 50, 2078-82 10.1016/j.tetlet.2009.02.127
19. Rolland, O.; Griffe, L.; Poupot, M.; Maraval, A.; Ouali, A.; Coppel, Y.; Fournie, J. J.; Bacquet, G.; Turrin, C. O.; Caminade, A. M.; Majoral, J. P.; Poupot, R. Tailored control and optimization of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex-vivo activation of human monocytes Chem.-Eur. J. 2008, 14 (16) 4836-50 10.1002/chem.200701063
20. Caminade, A. M.; Fruchon, S.; Turrin, C. O.; Poupot, M.; Ouali, A.; Maraval, A.; Garzoni, M.; Maly, M.; Furer, V.; Kovalenko, V.; Majoral, J. P.; Pavan, G. M.; Poupot, R. The key role of the scaffold on the efficiency of dendrimer nanodrugs Nat. Commun. 2015, 6, 7722 10.1038/ncomms8722
21. Hawker, C. J.; Malmström, E. E.; Frank, C. W.; Kampf, J. P. Exact linear analogs of dendritic polyether macromolecules: design, synthesis, and unique properties J. Am. Chem. Soc. 1997, 119 (41) 9903-4 10.1021/ja972027x
22. Hayder, M.; Poupot, M.; Baron, M.; Nigon, D.; Turrin, C. O.; Caminade, A. M.; Majoral, J. P.; Eisenberg, R. A.; Fournie, J. J.; Cantagrel, A.; Poupot, R.; Davignon, J. L. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis Sci. Transl. Med. 2011, 3 (81) 81ra35 10.1126/scitranslmed.3002212
23. Portevin, D.; Poupot, M.; Rolland, O.; Turrin, C. O.; Fournie, J. J.; Majoral, J. P.; Caminade, A. M.; Poupot, R. Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy J. Transl. Med. 2009, 7, 82 10.1186/1479-5876-7-82
24. Griffe, L.; Poupot, M.; Marchand, P.; Maraval, A.; Turrin, C. O.; Rolland, O.; Metivier, P.; Bacquet, G.; Fournie, J. J.; Caminade, A. M.; Poupot, R.; Majoral, J. P. Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers Angew. Chem., Int. Ed. 2007, 46 (14) 2523-6 10.1002/anie.200604651
25. Ben-Nun, A.; Kaushansky, N.; Kawakami, N.; Krishnamoorthy, G.; Berer, K.; Liblau, R.; Hohlfeld, R.; Wekerle, H. From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development J. Autoimmun. 2014, 54, 33-50 10.1016/j.jaut.2014.06.004
26. Gold, R.; Linington, C.; Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain 2006, 129 (Pt 8) 1953-71 10.1093/brain/awl075
27. Mendel, I.; de Rosbo, N. K.; Ben-Nun, A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells Eur. J. Immunol. 1995, 25 (7) 1951-9 10.1002/eji.1830250723
28. Mayer, M. C.; Meinl, E. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more Ther. Adv. Neurol. Disord. 2012, 5 (3) 147-59 10.1177/1756285611433772
29. Lucca, L. E.; Desbois, S.; Ramadan, A.; Ben-Nun, A.; Eisenstein, M.; Carrie, N.; Guery, J. C.; Sette, A.; Nguyen, P.; Geiger, T. L.; Mars, L. T.; Liblau, R. S. Bispecificity for myelin and neuronal self-antigens is a common feature of CD4 T cells in C57BL/6 mice J. Immunol. 2014, 193 (7) 3267-77 10.4049/jimmunol.1400523
30. Hofstetter, H. H.; Shive, C. L.; Forsthuber, T. G. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells J. Immunol. 2002, 169 (1) 117-25 10.4049/jimmunol.169.1.117
31. Cassan, C.; Piaggio, E.; Zappulla, J. P.; Mars, L. T.; Couturier, N.; Bucciarelli, F.; Desbois, S.; Bauer, J.; Gonzalez-Dunia, D.; Liblau, R. S. Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells J. Immunol. 2006, 177 (3) 1552-60 10.4049/jimmunol.177.3.1552
32. Miller, S. D.; Karpus, W. J.; Davidson, T. S. Experimental Autoimmune Encephalomyelitis in the Mouse Curr. Protoc. Immunol 2007, 15.1 10.1002/0471142735.im1501s77
33. Foster, C. A.; Mechtcheriakova, D.; Storch, M. K.; Balatoni, B.; Howard, L. M.; Bornancin, F.; Wlachos, A.; Sobanov, J.; Kinnunen, A.; Baumruker, T. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage Brain Pathol. 2009, 19 (2) 254-66 10.1111/j.1750-3639.2008.00182.x
34. Calabresi, P. A.; Radue, E. W.; Goodin, D.; Jeffery, D.; Rammohan, K. W.; Reder, A. T.; Vollmer, T.; Agius, M. A.; Kappos, L.; Stites, T.; Li, B.; Cappiello, L.; von Rosenstiel, P.; Lublin, F. D. Lublin, F. D., Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial Lancet Neurol. 2014, 13 (6) 545-56 10.1016/S1474-4422(14)70049-3
35. Getts, D. R.; Turley, D. M.; Smith, C. E.; Harp, C. T.; McCarthy, D.; Feeney, E. M.; Getts, M. T.; Martin, A. J.; Luo, X.; Terry, R. L.; King, N. J.; Miller, S. D. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells J. Immunol. 2011, 187 (5) 2405-17 10.4049/jimmunol.1004175
36. Joosten, L. A.; Lubberts, E.; Durez, P.; Helsen, M. M.; Jacobs, M. J.; Goldman, M.; van den Berg, W. B. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction Arthritis Rheum. 1997, 40 (2) 249-60 10.1002/art.1780400209
37. Mekala, D. J.; Alli, R. S.; Geiger, T. L. IL-10-dependent suppression of experimental allergic encephalomyelitis by Th2-differentiated, anti-TCR redirected T lymphocytes J. Immunol. 2005, 174 (6) 3789-97 10.4049/jimmunol.174.6.3789
38. Persson, S.; Mikulowska, A.; Narula, S.; O'Garra, A.; Holmdahl, R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats Scand. J. Immunol. 1996, 44 (6) 607-14 10.1046/j.1365-3083.1996.d01-355.x
39. Bettelli, E.; Pagany, M.; Weiner, H. L.; Linington, C.; Sobel, R. A.; Kuchroo, V. K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis J. Exp. Med. 2003, 197 (9) 1073-81 10.1084/jem.20021603
40. Stohlman, S. A.; Pei, L.; Cua, D. J.; Li, Z.; Hinton, D. R. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10 J. Immunol 1999, 163 (11) 6338-44
41. Jiang, X.; Xin, H.; Ren, Q.; Gu, J.; Zhu, L.; Du, F.; Feng, C.; Xie, Y.; Sha, X.; Fang, X. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment Biomaterials 2014, 35 (1) 518-29 10.1016/j.biomaterials.2013.09.094
42. Mdzinarishvili, A.; Sutariya, V.; Talasila, P. K.; Geldenhuys, W. J.; Sadana, P. Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke Drug Delivery Transl. Res. 2013, 3 (4) 309-317 10.1007/s13346-012-0117-8
43. Meister, S.; Zlatev, I.; Stab, J.; Docter, D.; Baches, S.; Stauber, R. H.; Deutsch, M.; Schmidt, R.; Ropele, S.; Windisch, M.; Langer, K.; Wagner, S.; von Briesen, H.; Weggen, S.; Pietrzik, C. U. Nanoparticulate flurbiprofen reduces amyloid-beta42 generation in an in vitro blood-brain barrier model Alzheimer's Res. Ther. 2013, 5 (6) 51 10.1186/alzrt225
44. Popov, M.; Abu Hammad, I.; Bachar, T.; Grinberg, S.; Linder, C.; Stepensky, D.; Heldman, E. Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes Eur. J. Pharm. Biopharm. 2013, 85 (3 Pt A) 381-9 10.1016/j.ejpb.2013.06.005
45. Fruchon, S.; Poupot, M.; Martinet, L.; Turrin, C. O.; Majoral, J. P.; Fournie, J. J.; Caminade, A. M.; Poupot, R. Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer J. Leukocyte Biol. 2008, 85 (3) 553-62 10.1189/jlb.0608371
46. Degboe, Y.; Fruchon, S.; Baron, M.; Nigon, D.; Turrin, C. O.; Caminade, A. M.; Poupot, R.; Cantagrel, A.; Davignon, J. L. Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent Arthritis Res. Ther 2014, 16 (2) R98 10.1186/ar4546
47. Ledall, J.; Fruchon, S.; Garzoni, M.; Pavan, G. M.; Caminade, A. M.; Turrin, C. O.; Blanzat, M.; Poupot, R. Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes Nanoscale 2015, 10.1039/C5NR03884G
48. Getts, D. R.; Terry, R. L.; Getts, M. T.; Deffrasnes, C.; Muller, M.; van Vreden, C.; Ashhurst, T. M.; Chami, B.; McCarthy, D.; Wu, H.; Ma, J.; Martin, A.; Shae, L. D.; Witting, P.; Kansas, G. S.; Kuhn, J.; Hafezi, W.; Campbell, I. L.; Reilly, D.; Say, J.; Brown, L.; White, M. Y.; Cordwell, S. J.; Chadban, S. J.; Thorp, E. B.; Bao, S.; Miller, S. D.; King, N. J. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles Sci. Transl. Med. 2014, 6 (219) 219ra7 10.1126/scitranslmed.3007563
49. Yeste, A.; Nadeau, M.; Burns, E. J.; Weiner, H. L.; Quintana, F. J. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (28) 11270-5 10.1073/pnas.1120611109
50. Ransohoff, R. M. Natalizumab for multiple sclerosis N. Engl. J. Med. 2007, 356 (25) 2622-9 10.1056/NEJMct071462
51. Brinkmann, V.; Billich, A.; Baumruker, T.; Heining, P.; Schmouder, R.; Francis, G.; Aradhye, S.; Burtin, P. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat. Rev. Drug Discovery 2010, 9 (11) 883-97 10.1038/nrd3248
52. Freedman, M. S.; Kaplan, J. M.; Markovic-Plese, S. Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis J. Clin. Cell. Immunol. 2013, 4 (4) PII: 100015 10.4172/2155-9899.1000152
53. Weber, M. S.; Prod'homme, T.; Youssef, S.; Dunn, S. E.; Rundle, C. D.; Lee, L.; Patarroyo, J. C.; Stuve, O.; Sobel, R. A.; Steinman, L.; Zamvil, S. S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease Nat. Med. 2007, 13 (8) 935-43 10.1038/nm1620
54. Fruchon, S.; Mouriot, S.; Thiollier, T.; Grandin, C.; Caminade, A. M.; Turrin, C. O.; Contamin, H.; Poupot, R. Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer Nanotoxicology 2015, 9 (4) 433-41 10.3109/17435390.2014.940406